Paper37519829
Investigating novel thiazolyl-indazole derivatives as scaffolds for SARS-CoV-2 MPro inhibitors.
Airas J and 8 others. Eur J Med Chem Rep, 2022. Cited by 3 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Investigating novel thiazolyl-indazole derivatives as scaffolds for SARS-CoV-2 MPro inhibitors. Papers, record 37519829. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37519829
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Investigating novel thiazolyl-indazole derivatives as scaffolds for SARS-CoV-2 MPro inhibitors.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References76
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31978945 | A Novel Coronavirus from Patients with Pneumonia in China, 2019. | N Engl J Med | 2020 | https://conductscience.org/library/papers/31978945 | PubMed |
| 2 | 34760153 | Discovery of SARS-CoV-2 Mpro peptide inhibitors from modelling substrate and ligand binding. | Chem Sci | 2021 | https://conductscience.org/library/papers/34760153 | PubMed |
| 3 | 33907666 | Triazole, imidazole, and thiazole-based compounds as potential agents against coronavirus. | Results Chem | 2021 | https://conductscience.org/library/papers/33907666 | PubMed |
| 4 | 26592383 | Routine Microsecond Molecular Dynamics Simulations with AMBER on GPUs. 2. Explicit Solvent Particle Mesh Ewald. | J Chem Theory Comput | 2013 | https://conductscience.org/library/papers/26592383 | PubMed |
| 5 | 12395429 | Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. Parameterization and validation. | J Comput Chem | 2002 | https://conductscience.org/library/papers/12395429 | PubMed |
| 6 | 33257760 | Conserved interactions required for inhibition of the main protease of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). | Sci Rep | 2020 | https://conductscience.org/library/papers/33257760 | PubMed |
| 7 | 32738988 | The SARS-CoV-2 main protease as drug target. | Bioorg Med Chem Lett | 2020 | https://conductscience.org/library/papers/32738988 | PubMed |
| 8 | 32329971 | Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility. | N Engl J Med | 2020 | https://conductscience.org/library/papers/32329971 | PubMed |
| 9 | 26596171 | PROPKA3: Consistent Treatment of Internal and Surface Residues in Empirical pKa Predictions. | J Chem Theory Comput | 2011 | https://conductscience.org/library/papers/26596171 | PubMed |
| 10 | 33316996 | Ensemble Docking Coupled to Linear Interaction Energy Calculations for Identification of Coronavirus Main Protease (3CLpro) Non-Covalent Small-Molecule Inhibitors. | Molecules | 2020 | https://conductscience.org/library/papers/33316996 | PubMed |
| 11 | 32015507 | A pneumonia outbreak associated with a new coronavirus of probable bat origin. | Nature | 2020 | https://conductscience.org/library/papers/32015507 | PubMed |
| 12 | 32887884 | Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease. | Nat Commun | 2020 | https://conductscience.org/library/papers/32887884 | PubMed |
| 13 | 15116359 | Development and testing of a general amber force field. | J Comput Chem | 2004 | https://conductscience.org/library/papers/15116359 | PubMed |
| 14 | 33091374 | Estimating the infection-fatality risk of SARS-CoV-2 in New York City during the spring 2020 pandemic wave: a model-based analysis. | Lancet Infect Dis | 2021 | https://conductscience.org/library/papers/33091374 | PubMed |
| 15 | 33596235 | Mapping major SARS-CoV-2 drug targets and assessment of druggability using computational fragment screening: Identification of an allosteric small-molecule binding site on the Nsp13 helicase. | PLoS One | 2021 | https://conductscience.org/library/papers/33596235 | PubMed |
| 16 | 20131845 | New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. | J Med Chem | 2010 | https://conductscience.org/library/papers/20131845 | PubMed |
| 17 | 25934508 | Recent applications of 1,3-thiazole core structure in the identification of new lead compounds and drug discovery. | Eur J Med Chem | 2015 | https://conductscience.org/library/papers/25934508 | PubMed |
| 18 | 33531496 | Structure of papain-like protease from SARS-CoV-2 and its complexes with non-covalent inhibitors. | Nat Commun | 2021 | https://conductscience.org/library/papers/33531496 | PubMed |
| 19 | 31995857 | Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. | N Engl J Med | 2020 | https://conductscience.org/library/papers/31995857 | PubMed |
| 20 | 11842254 | Conservation of substrate specificities among coronavirus main proteases. | J Gen Virol | 2002 | https://conductscience.org/library/papers/11842254 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41009862 | 1,5-Diarylidene-4-Piperidones as Promising Antifungal Candidates Against Cryptococcus neoformans. | Antibiotics (Basel) | 2025 | https://conductscience.org/library/papers/41009862 | PubMed |
| 39913331 | Scaling Graph Neural Networks to Large Proteins. | J Chem Theory Comput | 2025 | https://conductscience.org/library/papers/39913331 | PubMed |
| 37954960 | Exploring the disruption of SARS-CoV-2 RBD binding to hACE2. | Front Chem | 2023 | https://conductscience.org/library/papers/37954960 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AP2B1 | 163 | PubTator's text mining | https://conductscience.org/library/genes/163 | NCBI Gene |
| KCNH2 | 3757 | PubTator's text mining | https://conductscience.org/library/genes/3757 | NCBI Gene |
| PPP1CA | 5499 | PubTator's text mining | https://conductscience.org/library/genes/5499 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37519829
GET https://conductscience.org/api/papers/v1/37519829/references?page=2